Srijit Seal is a researcher and consultant specializing in chemoinformatics. His research is centred on using machine learning techniques, particularly modelling and interpretation of the Cell Painting assay, to predict drug bioactivity, safety, and toxicity. Seal actively engages in academic outreach, promoting the understanding of Artificial Intelligence and delivering seminars on its applications in drug discovery.